Search research articles
Contact Us
Filters
Showing results (191-200 of 214) with videos related to
Page
of 22
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 6, 2026
Physician Perspectives on Hepatitis C Treatment During Pregnancy: A Multinational Multispecialty Survey
Tatyana Kushner, Maria Buti, Mohamed El-Kassas, et al.
The New England Journal of Medicine
|
April 24, 2013
Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options
Ira M Jacobson, Stuart C Gordon, Kris V Kowdley, et al.
Journal of Hepatology
|
December 24, 2013
Boceprevir for chronic HCV genotype 1 infection in patients with prior treatment failure to peginterferon/ribavirin, including prior null response
John M Vierling, Mitchell Davis, Steven Flamm, et al.
Journal of Viral Hepatitis
|
August 29, 2022
Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: Data from the global liver registry
Zobair M Younossi, Ming-Lung Yu, Mohamed El-Kassas, et al.
Frontiers in Immunology
|
April 16, 2014
Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis
Carlo Selmi, Francesca Cavaciocchi, Ana Lleo, et al.
Lancet (London, England)
|
August 1, 2014
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study
Michael Manns, Stanislas Pol, Ira M Jacobson, et al.
Gastroenterology
|
August 4, 2016
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial
Edward J Gane, Kris V Kowdley, David Pound, et al.
The New England Journal of Medicine
|
April 24, 2013
Sofosbuvir for previously untreated chronic hepatitis C infection
Eric Lawitz, Alessandra Mangia, David Wyles, et al.
Antiviral Therapy
|
February 15, 2013
Resistance-associated amino acid variants associated with boceprevir plus pegylated interferon-α2b and ribavirin in patients with chronic hepatitis C in the SPRINT-1 trial
Robert A Ogert, John A Howe, John M Vierling, et al.
Journal of Viral Hepatitis
|
May 18, 2026
Impact of Fatigue on Patient-Reported Outcomes and Work Productivity in Chronic Hepatitis B and C: Insights From a Multinational Registry Study
Yusuf Yilmaz, Ming-Lung Yu, Khalid Alswat, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 214) with videos related to
Sort By:
Page
of 22
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 6, 2026
Physician Perspectives on Hepatitis C Treatment During Pregnancy: A Multinational Multispecialty Survey
Tatyana Kushner, Maria Buti, Mohamed El-Kassas, et al.
The New England Journal of Medicine
|
April 24, 2013
Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options
Ira M Jacobson, Stuart C Gordon, Kris V Kowdley, et al.
Journal of Hepatology
|
December 24, 2013
Boceprevir for chronic HCV genotype 1 infection in patients with prior treatment failure to peginterferon/ribavirin, including prior null response
John M Vierling, Mitchell Davis, Steven Flamm, et al.
Journal of Viral Hepatitis
|
August 29, 2022
Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: Data from the global liver registry
Zobair M Younossi, Ming-Lung Yu, Mohamed El-Kassas, et al.
Frontiers in Immunology
|
April 16, 2014
Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis
Carlo Selmi, Francesca Cavaciocchi, Ana Lleo, et al.
Lancet (London, England)
|
August 1, 2014
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study
Michael Manns, Stanislas Pol, Ira M Jacobson, et al.
Gastroenterology
|
August 4, 2016
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial
Edward J Gane, Kris V Kowdley, David Pound, et al.
The New England Journal of Medicine
|
April 24, 2013
Sofosbuvir for previously untreated chronic hepatitis C infection
Eric Lawitz, Alessandra Mangia, David Wyles, et al.
Antiviral Therapy
|
February 15, 2013
Resistance-associated amino acid variants associated with boceprevir plus pegylated interferon-α2b and ribavirin in patients with chronic hepatitis C in the SPRINT-1 trial
Robert A Ogert, John A Howe, John M Vierling, et al.
Journal of Viral Hepatitis
|
May 18, 2026
Impact of Fatigue on Patient-Reported Outcomes and Work Productivity in Chronic Hepatitis B and C: Insights From a Multinational Registry Study
Yusuf Yilmaz, Ming-Lung Yu, Khalid Alswat, et al.
Page
of 22